1 min read
Niagen Bioscience Posts $27.2 Million Revenue as GAAP EPS Misses
Revenue was $4.7 million below estimates, and GAAP earnings per share of negative $0.01 missed by $0.01.

Revenue came in at $27.2 million, $4.7 million below estimates. GAAP earnings per share was negative $0.01, a miss of $0.01.